Valerie Morisset insider trades: Eliem Therapeutics (ELYM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Valerie reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | ELYM | ↓ Sell | 129,206 | $7.65 | $988K | Direct | Jul 23, 2024 (1d) |
| Jul 18, 2024 | ELYM | ↓ Sell | 41,783 | $6.93 | $289K | Direct | Jul 19, 2024 (1d) |
| Jul 16, 2024 | ELYM | ↓ Sell | 50,000 | $7.13 | $357K | Direct | Jul 17, 2024 (1d) |
| Jul 15, 2024 | ELYM | ↓ Sell | 92,377 | $7.04 | $651K | Direct | Jul 16, 2024 (1d) |
| Jul 11, 2024 | ELYM | ↓ Sell | 105,931 | $6.95 | $737K | Direct | Jul 11, 2024 (0d) |
| Jul 5, 2024 | ELYM | ↓ Sell | 12,342 | $7.06 | $87K | Direct | Jul 9, 2024 (4d) |
| Jul 3, 2024 | ELYM | ↓ Sell | 50,000 | $6.76 | $338K | Direct | Jul 3, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Valerie Morisset's insider trades
Valerie Morisset is EVP, R&D and CSO at Eliem Therapeutics (ELYM). Since Jul 3, 2024, Valerie has reported no open-market purchases and 7 sales worth $3.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (4 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELYM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.